Key result
Quercetin attenuates structural and electrical remodeling in cardiac arrhythmia by inhibiting oxidative stress, fibrosis, inflammation, and apoptosis in preclinical models.
Why the study?
Cardiac arrhythmia is a prevalent and potentially fatal cardiovascular disease, prompting interest in the pharmacological actions and molecular targets of quercetin as a therapeutic strategy.
Does quercetin prevent or ameliorate cardiac arrhythmia in preclinical models?
Does quercetin prevent or ameliorate cardiac arrhythmia in preclinical models?
Preclinical evidence suggests quercetin may prevent or ameliorate cardiac arrhythmia by attenuating structural and electrical remodeling.
No takes yet. Share an insight, caveat, or question.
Quercetin may attenuate arrhythmia remodeling preclinically; leaves open clinical translation and randomized human trials.
Zhou et al. (2022) conducted a review in Cardiac arrhythmia. Quercetin was evaluated. Quercetin attenuates structural and electrical remodeling in cardiac arrhythmia by inhibiting oxidative stress, fibrosis, inflammation, and apoptosis in preclinical models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: